Clinical trials
Observational Pulmonary Atelectasis trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Istanbul University | 3 |
| Zonguldak Bulent Ecevit University | 3 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 2 |
| Fatih Sultan Mehmet Training and Research Hospital | 2 |
| Hacettepe University | 2 |
| Ankara Ataturk Sanatorium Training and Research Hospital | 1 |
| Ankara Etlik City Hospital | 1 |
| Ankara University | 1 |
| Cumhuriyet University | 1 |
| Derince Training and Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Atelectasis | 24 |
| Acute Lung Injury | 3 |
| Pneumonia | 3 |
| Pneumothorax | 2 |
| Premature Birth | 2 |
| Respiratory Distress Syndrome | 2 |
| Respiratory Insufficiency | 2 |
| Bronchial Spasm | 1 |
| Cholecystitis | 1 |
| Gallstones | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.